Tetrabenazinum
compositum chemicum
Tetrabenazinum est medicamentum in malis motuum hyperkineticis tractandis, ut morbo Huntington et dystoniis atque dyskinesia tardiva.
Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt. |
Cognitores | |
---|---|
ChemSpider | 5796 |
PubChem | 6018 |
DrugBank | DB04844 |
Natura chemica | |
Formula summarum | C 19H 27NO 3 |
Massa molaris | 317.427 g/mol |
Natura pharmacologica | |
Codex ATC | N07XX06 (WHO) |
Metabolismus | iecore (hepaticus) |
Excretio | renibus: 75%, faecibus: 7-16% |
Ad usum therapeuticum | |
Applicatio | per os |
Natura Tetrabenazini
recensereNatura chemica
recensereTetrabenazinum est (IUPAC) (RR,SS)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo-[a]-chinolinum.
Massa molaris est 317.427 g/mol.
Natura pharmacologica
recenserePharmacodynamica
recensereTetrabenazinum receptoria dopamini obsidet inhibetque. Praeterea neurotransmissores monoaminergicos consumit.
Pharmacocinetica
recensereExcretio est per imprimis urinas, minus per biles.
Effectus Tetrabenazini
recensereEffectus secundarii
recensereExempli (!) sunt[1]:
Nexus interni
Notae
recensere- ↑ Jankovic J., Beach J. (Feb 1997). "Long-term effects of tetrabenazine in hyperkinetic movement disorders". Neurology 48 (2): 385-62